Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes
Recruiting
Phase 3
Interventional Study
Embryo Transfer
IVF
Infertility
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 43
- Sex
- Female
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Beni-Suef University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this work was to investigate the effect of different vasodilators as pentoxifylline in women with unexplained infertility using IVF
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* as good quality day five frozen embryos.
Exclusion Criteria:
* history of endocrine diseases,
* history of any previous surgery that couldm compromise the integrity of endometrium,
* cardiovascular, renal and liver diseases,
Contacts